Prevention of Left Ventricle Thrombus Formation: Time for Action

Free article

Comment

Anastasios Apostolos et al. JACC Cardiovasc Interv. 2022.

Free article

. 2022 Jun 27;15(12):1284-1285.

doi: 10.1016/j.jcin.2022.04.039.

No abstract available

Comment in

Reply: "Prevention of Left Ventricle Thrombus Formation: Time for Action".
Zhang Z, Si D, Zhang Q, Zhang W. Zhang Z, et al. JACC Cardiovasc Interv. 2022 Jun 27;15(12):1286-1288. doi: 10.1016/j.jcin.2022.05.013. JACC Cardiovasc Interv. 2022. PMID: 35738753 No abstract available.

Preventing Left Ventricular Thrombus Formation: Another Reason to Use Very Low-Dose Rivaroxaban?
Cavender MA, Eubanks GC. Cavender MA, et al. JACC Cardiovasc Interv. 2022 Apr 25;15(8):873-875. doi: 10.1016/j.jcin.2022.02.024. Epub 2022 Mar 30. JACC Cardiovasc Interv. 2022. PMID: 35367169 No abstract available.
Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction.
Zhang Z, Si D, Zhang Q, Jin L, Zheng H, Qu M, Yu M, Jiang Z, Li D, Li S, Yang P, He Y, Zhang W. Zhang Z, et al. JACC Cardiovasc Interv. 2022 Apr 25;15(8):861-872. doi: 10.1016/j.jcin.2022.01.285. Epub 2022 Mar 30. JACC Cardiovasc Interv. 2022. PMID: 35367170 Clinical Trial.